Essential role for ERK2 mitogen-activated protein kinase in placental development. 2003

Naoya Hatano, and Yoshiko Mori, and Masatsugu Oh-hora, and Atsushi Kosugi, and Takahiko Fujikawa, and Naoya Nakai, and Hitoshi Niwa, and Jun-ichi Miyazaki, and Toshiyuki Hamaoka, and Masato Ogata
Department of Pathology and Pathophysiology, Osaka University Graduate School of Medicine, 2-2 Yamadaoka, Japan.

BACKGROUND Extracellular signal-regulated kinase 2 (ERK2) has been implicated in cell proliferation, differentiation, and survival. However, its role in vivo remains to be determined. RESULTS Here we show that the targeted disruption of the mouse ERK2 gene results in embryonic lethality by E11.5 and severe abnormality of the placenta. In these animals, the labyrinthine layer of the placenta is very thin and few foetal blood vessels are observed. ERK2 mutants can be rescued by the transgenic expression of ERK2, demonstrating that these abnormalities are caused by ERK2-deficiency. Although ERK2-deficient fetuses are much smaller than wild-type littermates, this seems to be secondary to malfunction of the placenta. When the placental defect is rescued by tetraploid-aggregation, ERK2-deficient foetuses grow as well as littermate controls. CONCLUSIONS These observations indicate that ERK2 is essential for placental development and suggest that ERK2 in the trophoblast compartment may be indispensable for the vascularization of the labyrinth.

UI MeSH Term Description Entries
D008297 Male Males
D008810 Mice, Inbred C57BL One of the first INBRED MOUSE STRAINS to be sequenced. This strain is commonly used as genetic background for transgenic mouse models. Refractory to many tumors, this strain is also preferred model for studying role of genetic variations in development of diseases. Mice, C57BL,Mouse, C57BL,Mouse, Inbred C57BL,C57BL Mice,C57BL Mice, Inbred,C57BL Mouse,C57BL Mouse, Inbred,Inbred C57BL Mice,Inbred C57BL Mouse
D008822 Mice, Transgenic Laboratory mice that have been produced from a genetically manipulated EGG or EMBRYO, MAMMALIAN. Transgenic Mice,Founder Mice, Transgenic,Mouse, Founder, Transgenic,Mouse, Transgenic,Mice, Transgenic Founder,Transgenic Founder Mice,Transgenic Mouse
D010920 Placenta A highly vascularized mammalian fetal-maternal organ and major site of transport of oxygen, nutrients, and fetal waste products. It includes a fetal portion (CHORIONIC VILLI) derived from TROPHOBLASTS and a maternal portion (DECIDUA) derived from the uterine ENDOMETRIUM. The placenta produces an array of steroid, protein and peptide hormones (PLACENTAL HORMONES). Placentoma, Normal,Placentome,Placentas,Placentomes
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D005260 Female Females
D005314 Embryonic and Fetal Development Morphological and physiological development of EMBRYOS or FETUSES. Embryo and Fetal Development,Prenatal Programming,Programming, Prenatal
D005804 Genes, Lethal Genes whose loss of function or gain of function MUTATION leads to the death of the carrier prior to maturity. They may be essential genes (GENES, ESSENTIAL) required for viability, or genes which cause a block of function of an essential gene at a time when the essential gene function is required for viability. Alleles, Lethal,Allele, Lethal,Gene, Lethal,Lethal Allele,Lethal Alleles,Lethal Gene,Lethal Genes
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D014162 Transfection The uptake of naked or purified DNA by CELLS, usually meaning the process as it occurs in eukaryotic cells. It is analogous to bacterial transformation (TRANSFORMATION, BACTERIAL) and both are routinely employed in GENE TRANSFER TECHNIQUES. Transfections

Related Publications

Naoya Hatano, and Yoshiko Mori, and Masatsugu Oh-hora, and Atsushi Kosugi, and Takahiko Fujikawa, and Naoya Nakai, and Hitoshi Niwa, and Jun-ichi Miyazaki, and Toshiyuki Hamaoka, and Masato Ogata
September 2000, Proceedings of the National Academy of Sciences of the United States of America,
Naoya Hatano, and Yoshiko Mori, and Masatsugu Oh-hora, and Atsushi Kosugi, and Takahiko Fujikawa, and Naoya Nakai, and Hitoshi Niwa, and Jun-ichi Miyazaki, and Toshiyuki Hamaoka, and Masato Ogata
October 2003, EMBO reports,
Naoya Hatano, and Yoshiko Mori, and Masatsugu Oh-hora, and Atsushi Kosugi, and Takahiko Fujikawa, and Naoya Nakai, and Hitoshi Niwa, and Jun-ichi Miyazaki, and Toshiyuki Hamaoka, and Masato Ogata
November 2000, Biochemistry,
Naoya Hatano, and Yoshiko Mori, and Masatsugu Oh-hora, and Atsushi Kosugi, and Takahiko Fujikawa, and Naoya Nakai, and Hitoshi Niwa, and Jun-ichi Miyazaki, and Toshiyuki Hamaoka, and Masato Ogata
May 2000, Biochemistry,
Naoya Hatano, and Yoshiko Mori, and Masatsugu Oh-hora, and Atsushi Kosugi, and Takahiko Fujikawa, and Naoya Nakai, and Hitoshi Niwa, and Jun-ichi Miyazaki, and Toshiyuki Hamaoka, and Masato Ogata
October 2002, The Journal of biological chemistry,
Naoya Hatano, and Yoshiko Mori, and Masatsugu Oh-hora, and Atsushi Kosugi, and Takahiko Fujikawa, and Naoya Nakai, and Hitoshi Niwa, and Jun-ichi Miyazaki, and Toshiyuki Hamaoka, and Masato Ogata
April 2014, Oncogene,
Naoya Hatano, and Yoshiko Mori, and Masatsugu Oh-hora, and Atsushi Kosugi, and Takahiko Fujikawa, and Naoya Nakai, and Hitoshi Niwa, and Jun-ichi Miyazaki, and Toshiyuki Hamaoka, and Masato Ogata
December 1999, The Journal of biological chemistry,
Naoya Hatano, and Yoshiko Mori, and Masatsugu Oh-hora, and Atsushi Kosugi, and Takahiko Fujikawa, and Naoya Nakai, and Hitoshi Niwa, and Jun-ichi Miyazaki, and Toshiyuki Hamaoka, and Masato Ogata
June 2009, Cancer research,
Naoya Hatano, and Yoshiko Mori, and Masatsugu Oh-hora, and Atsushi Kosugi, and Takahiko Fujikawa, and Naoya Nakai, and Hitoshi Niwa, and Jun-ichi Miyazaki, and Toshiyuki Hamaoka, and Masato Ogata
November 2001, The Journal of biological chemistry,
Naoya Hatano, and Yoshiko Mori, and Masatsugu Oh-hora, and Atsushi Kosugi, and Takahiko Fujikawa, and Naoya Nakai, and Hitoshi Niwa, and Jun-ichi Miyazaki, and Toshiyuki Hamaoka, and Masato Ogata
January 2014, PloS one,
Copied contents to your clipboard!